1. Home
  2. MRBK vs KPTI Comparison

MRBK vs KPTI Comparison

Compare MRBK & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$18.12

Market Cap

206.1M

Sector

Finance

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$9.04

Market Cap

194.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
KPTI
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.1M
194.8M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
MRBK
KPTI
Price
$18.12
$9.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$20.75
$16.00
AVG Volume (30 Days)
79.7K
439.0K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
3.05%
N/A
EPS Growth
30.34
N/A
EPS
0.17
N/A
Revenue
$6,316,000.00
$146,067,000.00
Revenue This Year
$25.40
N/A
Revenue Next Year
$8.15
$22.36
P/E Ratio
$104.94
N/A
Revenue Growth
10.13
0.57
52 Week Low
$11.17
$3.65
52 Week High
$21.59
$10.99

Technical Indicators

Market Signals
Indicator
MRBK
KPTI
Relative Strength Index (RSI) 51.08 54.86
Support Level $18.10 $5.43
Resistance Level $18.33 $9.32
Average True Range (ATR) 0.38 0.88
MACD 0.14 0.10
Stochastic Oscillator 97.66 64.79

Price Performance

Historical Comparison
MRBK
KPTI

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: